Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with cervical cancer, multiple sclerosis, and insomnia.
Children who receive growth hormone to treat short stature or hormone deficiency may be at an increased risk of ischemic stroke as young adults, suggests a new European study.
The FDA approved a once-daily, long-term olodaterol inhalation spray to treat patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema with airflow obstruction.